Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts

被引：13

作者：

Tokuda, Haruhiko ^{[1
,2
]}

Takai, Shinji ^{[2
]}

Hanai, Yoshiteru ^{[1
,2
]}

Harada, Atsushi ^{[3
]}

Matsushima-Nishiwaki, Rie ^{[2
]}

Kato, Hisaaki ^{[2
,4
]}

Ogura, Shinji ^{[4
]}

Kozawa, Osamu ^{[2
]}

机构：

[1] Natl Hosp Geriatr Med, Dept Clin Lab, Natl Ctr Geriatr & Gerontol, Aichi 4748511, Japan

[2] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan

[3] Natl Hosp Geriatr Med, Dept Funct Restorat, Natl Ctr Geriatr & Gerontol, Aichi, Japan

[4] Gifu Univ, Dept Emergency & Disaster Med, Grad Sch Med, Gifu, Japan

来源：

JOURNAL OF BONE AND MINERAL METABOLISM | 2008年 / 26卷 / 04期

关键词：

FGF; PDGF; MAP kinase; VEGF; osteoblast;

D O I：

10.1007/s00774-007-0829-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We previously reported that basic fibroblast growth factor (FGF-2) stimulates the release of vascular endothelial growth factor (VEGF) via p44/p42 mitogenactivated protein (MAP) kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in osteoblastlike MC3T3-E1 cells. In the present study, we investigated the effect of platelet-derived growth factor-BB (PDGF-BB) on FGF-2-induced VEGF release in MC3T3-E1 cells. PDGF-BB significantly enhanced the FGF-2-stimulated VEGF release. The amplifying effect of PDGF-BB was dose dependent in the range between 0.1 and 30 ng/ml. AG1295, a selective inhibitor of PDGF receptor kinase, which reduced the autophosphorylation of PDGF receptor-(R), suppressed the enhancement by PDGF-BB without affecting the FGF-2 effect. PDGF-BB failed to strengthen the FGF-2-induced phosphorylation of p44/p42 MAP kinase or SAPK/JNK. The amplification by PDGF-BB of FGF-2-stimulated VEGF release was reduced by PD98059, a specific inhibitor of MEK, or SP600125, a specific inhibitor of SAPK/JNK. These results strongly suggest that PDGF-BB potentiates FGF-2-stimulated VEGF release at a point downstream from p44/p42 MAP kinase and SAPK/JNK in osteoblasts.

引用

页码：335 / 341

页数：7

共 33 条

[1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].

ALESSI, DR ;

CUENDA, A ;

COHEN, P ;

DUDLEY, DT ;

SALTIEL, AR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494

[2]

BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565

[3] SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].

Bennett, BL ;

Sasaki, DT ;

Murray, BW ;

O'Leary, EC ;

Sakata, ST ;

Xu, WM ;

Leisten, JC ;

Motiwala, A ;

Pierce, S ;

Satoh, Y ;

Bhagwat, SS ;

Manning, AM ;

Anderson, DW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686

[4]

BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165

[5] EARLY HISTOLOGICAL AND ULTRASTRUCTURAL-CHANGES IN MEDULLARY FRACTURE CALLUS [J].

BRIGHTON, CT ;

HUNT, RM .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1991, 73A (06) :832-847

[6]

Canalis E, 2002, PRINCIPLES BONE BIOL, V2, P817

[7] TOWARD A MOLECULAR UNDERSTANDING OF SKELETAL DEVELOPMENT [J].

ERLEBACHER, A ;

FILVAROFF, EH ;

GITELMAN, SE ;

DERYNCK, R .

CELL, 1995, 80 (03) :371-378

[8] The biology of vascular endothelial growth factor [J].

Ferrara, N ;

DavisSmyth, T .

ENDOCRINE REVIEWS, 1997, 18 (01) :4-25

[9] VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation [J].

Gerber, HP ;

Vu, TH ;

Ryan, AM ;

Kowalski, J ;

Werb, Z ;

Ferrara, N .

NATURE MEDICINE, 1999, 5 (06) :623-628

[10] Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I [J].

Goad, DL ;

Rubin, J ;

Wang, H ;

Tashjian, AH ;

Patterson, C .

ENDOCRINOLOGY, 1996, 137 (06) :2262-2268

← 1 2 3 4 →